Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-22

FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s supplemental application for tacrolimus (generic) under ANDA 091195, enabling continued approval of a tacrolimus product f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)